{"altmetric_id": 82639539, "counts": {"readers": {"citeulike": "0", "mendeley": "40", "connotea": "0"}, "total": {"posts_count": 21}, "twitter": {"unique_users_count": 8, "posts_count": 9}, "news": {"unique_users_count": 12, "unique_users": ["digital_journal", "economy_watch", "pr_newswire", "ticker_tech", "finanzen_ch", "vb_profiles", "benzinga", "the_street", "kpvi", "wfmz_tv_69", "profitquotes_com", "spoke"], "posts_count": 12}}, "citation": {"altmetric_jid": "532721422a83ee84788b4567", "authors": ["Per Niklas Hedde", "Timothy J Abram", "Aarti Jain", "Rie Nakajima", "Rafael Ramiro de Assis", "Trevor Pearce", "Algis Jasinskas", "Melody N Toosky", "Saahir Khan", "Philip L Felgner", "Enrico Gratton", "Weian Zhao"], "doi": "10.1101/2020.05.22.111518", "first_seen_on": "2020-05-25T11:45:05+00:00", "issns": [], "journal": "bioRxiv", "last_mentioned_on": 1593634871, "links": ["https://www.biorxiv.org/content/10.1101/2020.05.22.111518v1", "https://doi.org/10.1101/2020.05.22.111518"], "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/05/23/2020.05.22.111518.full.pdf", "pubdate": "2020-05-23T00:00:00+00:00", "publisher": "Cold Spring Harbor Laboratory", "title": "A Modular Microarray Imaging System for Highly Specific COVID-19 Antibody Testing", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/636149fa-0674-38cb-8b02-32c0d4e4e501/"}, "altmetric_score": {"score": 88.6, "score_history": {"1y": 88.6, "6m": 0, "3m": 0, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 88.6}, "context_for_score": {"all": {"total_number_of_other_articles": 16602274, "mean": 9.2446379517589, "rank": 263497, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 16339941, "rank_type": "exact", "sample_size": 16602274, "percentile": 98}, "similar_age_3m": {"total_number_of_other_articles": 289922, "mean": 19.82380502342, "rank": 9964, "this_scored_higher_than_pct": 96, "this_scored_higher_than": 279963, "rank_type": "exact", "sample_size": 289922, "percentile": 96}, "this_journal": {"total_number_of_other_articles": 107929, "mean": 13.652356567744, "rank": 1747, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 106197, "rank_type": "exact", "sample_size": 107929, "percentile": 98}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 8397, "mean": 18.644394188401, "rank": 197, "this_scored_higher_than_pct": 97, "this_scored_higher_than": 8201, "rank_type": "exact", "sample_size": 8397, "percentile": 97}}}, "demographics": {"poster_types": {"member_of_the_public": 8}, "users": {"twitter": {"cohorts": {"Members of the public": 8}}, "mendeley": {"by_status": {"Student  > Postgraduate": 3, "Professor > Associate Professor": 1, "Researcher": 5, "Student  > Master": 1, "Student  > Ph. D. Student": 5, "Student  > Bachelor": 10, "Student  > Doctoral Student": 2, "Other": 2, "Librarian": 5}, "by_discipline": {"Engineering": 2, "Chemistry": 1, "Neuroscience": 1, "Medicine and Dentistry": 15, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 2, "Computer Science": 1, "Agricultural and Biological Sciences": 1, "Nursing and Health Professions": 2, "Biochemistry, Genetics and Molecular Biology": 3, "Environmental Science": 1}}}, "geo": {"twitter": {"US": 3, "GB": 1, "MX": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "1949132852"}, "tweet_id": "1264429624777375750"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "748908558066982916"}, "tweet_id": "1264429625628909568"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "1256280966101942273"}, "tweet_id": "1264524965291986945"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "745573975632248832"}, "tweet_id": "1264541950876823554"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "238401331"}, "tweet_id": "1264559516160602112"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "852072878430224384"}, "tweet_id": "1264674356145209344"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1265961782826467330"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1265961861234778112"}, {"license": "gnip", "citation_ids": [82639539], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1270202668355469312"}], "news": [{"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42495811070&p=1pl&v=1&x=gKxrsujo4JSZpN9_Oam7Cg", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T17:22:44+00:00", "summary": "- ( Newswire.com ) \u200b\u200b\u200bNanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use\u2026", "author": {"name": "Digital Journal", "url": "http://www.digitaljournal.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/223/normal/image.png?1371424893"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496286345&p=1pl&v=1&x=XqthoISuI5rLT0kJzEZ3Hw", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T18:40:27+00:00", "summary": "- ( Newswire.com ) \u200b\u200b\u200bNanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use\u2026", "author": {"name": "Economy Watch", "url": "http://www.economywatch.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/918/normal/Screen_Shot_2016-01-27_at_14.58.39.png?1453906769"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496615897&p=1pl&v=1&x=akLZiwya9aSKzTKocllGoQ", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:32:00+00:00", "summary": "/PRNewswire/ --. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and adoption of\u2026", "author": {"name": "PR Newswire", "url": "http://www.prnewswire.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/545/normal/Screen_Shot_2016-01-06_at_16.29.18.png?1452097789"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496619675&p=1pl&v=1&x=P8xzbhMde7vxwcqNGAN5Jg", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:37:17+00:00", "summary": "IRVINE, Calif., July 1, 2020 /PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc.", "author": {"name": "Ticker Tech", "url": "http://www.tickertech.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/724/normal/Screen_Shot_2016-01-26_at_15.37.40.png?1453822700"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496628889&p=1pl&v=1&x=L_Y9QImzaRQ_kAy8NmnobQ", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:32:00+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and\u2026", "author": {"name": "Finanzen.ch", "url": "https://www.finanzen.ch/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/573/normal/Capture26.PNG?1575886265"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496664050&p=1pl&v=1&x=Ht5nLQq2TYVTYBVsJ6983A", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:44:52+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and\u2026", "author": {"name": "VB Profiles", "url": "https://www.vbprofiles.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/839/normal/58.JPG?1576557158"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496669481&p=1pl&v=1&x=rlfWFJB8Vz-a814q3fFuMQ", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:32:00+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and\u2026", "author": {"name": "Benzinga", "url": "http://www.benzinga.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/738/normal/Screen_Shot_2016-01-26_at_15.59.27.png?1453824001"}}, {"title": "Nanommune Partners With Velox Biosystems To Offer Laboratory Testing Of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496724271&p=1pl&v=1&x=jN3JAOfdq7J1jlbScbP4dA", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:32:00+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. IRVINE, Calif., July 1, 2020 /PRNewswire/ -- Nanommune Inc.", "author": {"name": "The Street", "url": "http://www.thestreet.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/809/normal/Screen_Shot_2016-01-27_at_10.05.56.png?1453889412"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496738679&p=1pl&v=1&x=r9TvrwPCfaOx2-j5c7tmEw", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:32:00+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and\u2026", "author": {"name": "KPVI", "url": "https://www.kpvi.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/663/normal/Capture_kvpi.PNG?1576132656"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496742127&p=1pl&v=1&x=cQCUbRy3xooY_2mtZoJh1w", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T19:32:00+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and\u2026", "author": {"name": "WFMZ-TV 69", "url": "https://www.wfmz.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/256/normal/Capture_62.PNG?1567141986"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496774083&p=1pl&v=1&x=NWWnysANkY2WaYZMRORMCA", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T20:04:25+00:00", "summary": "IRVINE, Calif., July 1, 2020 /PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc.", "author": {"name": "ProfitQuotes.com", "url": "http://www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=201908201908021405PR_NEWS_USPR_____DC29726", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/276/normal/logo7E.jpg?1567155044"}}, {"title": "Nanommune Partners With Velox Biosystems to Offer Laboratory Testing of COVID-19 Serological Assays", "url": "http://ct.moreover.com/?a=42496869407&p=1pl&v=1&x=Rpnr88R0DdPbt-SYD37wvw", "license": "public", "citation_ids": [79974082, 82639539], "posted_on": "2020-07-01T20:21:11+00:00", "summary": "/PRNewswire/ -- Nanommune Inc. and Velox Biosystems, Inc. have announced a partnership to bring to market rapid, high-throughput laboratory testing and consulting services for clinicians, laboratories, and researchers to accelerate their use and\u2026", "author": {"name": "Spoke", "url": "http://www.spoke.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/787/normal/Capture14.PNG?1576476237"}}]}, "score": 88.6, "images": {"small": "https://badges.altmetric.com/?size=64&score=89&types=mmmmmttt", "medium": "https://badges.altmetric.com/?size=100&score=89&types=mmmmmttt", "large": "https://badges.altmetric.com/?size=180&score=89&types=mmmmmttt"}}